Cargando…
Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report
BACKGROUND: Recent advances in cancer immunotherapy have been remarkable, with many reports on the clinical effects of immune checkpoint inhibitors. Nivolumab has been covered by the national health insurance in Japan as a third-line agent for advanced and recurrent gastric cancer since September 20...
Autores principales: | Takami, Tomoya, Yasuda, Koji, Uozumi, Nozomi, Musiake, Yutaka, Shintani, Hiroshi, Kataoka, Naoki, Yamaguchi, Tomoyuki, Makimoto, Shinichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690463/ https://www.ncbi.nlm.nih.gov/pubmed/34930435 http://dx.doi.org/10.1186/s13256-021-03200-x |
Ejemplares similares
-
Sigmoid Volvulus with Widespread Bowel Ischemia after Endoscopic Reduction Successfully Treated with Elective Laparoscopic Surgery
por: Yasuda, Koji, et al.
Publicado: (2020) -
Subdiaphragmatic abscess due to penetration of a duodenal ulcer successfully treated with endoscopic transgastric drainage: a case report
por: Takami, Tomoya, et al.
Publicado: (2021) -
Evaluation of additional gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer
por: Makimoto, Shinichiro, et al.
Publicado: (2022) -
Cases of two patients with aortoduodenal fistula who underwent emergency operation
por: Makimoto, Shinichiro, et al.
Publicado: (2020) -
Calcification and abscess formation around the catheter tip of a central venous access port: a case report
por: Takami, Tomoya, et al.
Publicado: (2020)